PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'National Infection Service, Public Health England, 61 Colindale Avenue, London, NW9 5EQ, United Kingdom. Electronic address: sara.croxford@phe.gov.uk.\', \'National Infection Service, Public Health England, 61 Colindale Avenue, London, NW9 5EQ, United Kingdom.\', \'National Infection Service, Public Health England, 61 Colindale Avenue, London, NW9 5EQ, United Kingdom; Joint Biosecurity Centre, Wellington House, 133-155 Waterloo Road, London, SE1 8UG, United Kingdom.\', \'National Infection Service, Public Health England, 61 Colindale Avenue, London, NW9 5EQ, United Kingdom; Public Health Institute, Liverpool John Moores University, 3rd Floor, Exchange Station, Tithebarn Street, Liverpool, L2 2QP, United Kingdom.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • S0033-3506(21)00010-X10.1016/j.puhe.2021.01.004
?:hasPublicationType
?:journal
  • Public health
is ?:pmid of
?:pmid
?:pmid
  • 33601307
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.663
?:rankingScore_hIndex
  • 63
?:title
  • Preliminary indications of the burden of COVID-19 among people who inject drugs in England and Northern Ireland and the impact on access to health and harm reduction services.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all